Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 846

1.

Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer.

Takada K, Kashiwagi S, Goto W, Asano Y, Takahashi K, Takashima T, Tomita S, Ohsawa M, Hirakawa K, Ohira M.

J Transl Med. 2018 Apr 3;16(1):86. doi: 10.1186/s12967-018-1460-4.

2.

Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression.

Asano Y, Kashiwagi S, Goto W, Takada K, Takahashi K, Morisaki T, Fujita H, Takashima T, Tomita S, Ohsawa M, Hirakawa K, Ohira M.

J Transl Med. 2018 Apr 4;16(1):87. doi: 10.1186/s12967-018-1458-y.

3.

Butyrylcholinesterase level as an independent factor of erythropoiesis-stimulating agent resistance in patients on maintenance hemodialysis: a single-center cross-sectional study.

Okamoto T, Hatakeyama S, Tanaka Y, Imanishi K, Takashima T, Saitoh F, Koie T, Suzuki T, Ohyama C.

Clin Exp Nephrol. 2018 Mar 29. doi: 10.1007/s10157-018-1569-z. [Epub ahead of print]

PMID:
29600410
4.

Prediction of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer by Subtype Using Tumor-infiltrating Lymphocytes.

Asano Y, Kashiwagi S, Goto W, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

Anticancer Res. 2018 Apr;38(4):2311-2321.

PMID:
29599354
5.

Analysis of HER Family (HER1-4) Expression as a Biomarker in Combination Therapy with Pertuzumab, Trastuzumab and Docetaxel for Advanced HER2-positive Breast Cancer.

Takada K, Kashiwagi S, Goto W, Asano Y, Morisaki T, Fujita H, Takashima T, Ohsawa M, Hirakawa K, Ohira M.

Anticancer Res. 2018 Apr;38(4):2285-2294.

PMID:
29599351
6.

The relationship between poor nutritional status and progression of aortic calcification in patients on maintenance hemodialysis.

Okamoto T, Hatakeyama S, Kodama H, Horiguchi H, Kubota Y, Kido K, Momota M, Hosogoe S, Tanaka Y, Takashima T, Saitoh F, Suzuki T, Ohyama C.

BMC Nephrol. 2018 Mar 20;19(1):71. doi: 10.1186/s12882-018-0872-y.

7.

Correction to: Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer.

Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

Biomark Res. 2018 Mar 7;6:9. doi: 10.1186/s40364-018-0124-0. eCollection 2018.

8.

Implication of exercise interventions on sleep disturbance in patients with pancreatic cancer: a study protocol for a randomised controlled trial.

Yoh K, Nishikawa H, Enomoto H, Ishii N, Iwata Y, Ishii A, Yuri Y, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2018 Feb 16;5(1):e000196. doi: 10.1136/bmjgast-2017-000196. eCollection 2018.

9.

Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trial.

Yoh K, Nishikawa H, Enomoto H, Ishii N, Iwata Y, Ishii A, Yuri Y, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2018 Feb 7;5(1):e000194. doi: 10.1136/bmjgast-2017-000194. eCollection 2018.

10.

Clinical impact of physical exercise on sleep disorder as assessed by actigram in patients with chronic pancreatitis: a study protocol for a randomised controlled trial.

Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Yuri Y, Ishii N, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2018 Feb 14;5(1):e000193. doi: 10.1136/bmjgast-2017-000193. eCollection 2018.

11.

Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment.

Kashiwagi S, Tsujio G, Asano Y, Goto W, Takada K, Takahashi K, Morisaki T, Fujita H, Takashima T, Tomita S, Ohsawa M, Hirakawa K, Ohira M.

J Transl Med. 2018 Mar 9;16(1):54. doi: 10.1186/s12967-018-1443-5.

12.

Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response.

Kobayashi N, Iijima H, Tada T, Kumada T, Yoshida M, Aoki T, Nishimura T, Nakano C, Takata R, Yoh K, Ishii A, Takashima T, Sakai Y, Aizawa N, Nishikawa H, Ikeda N, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S.

Eur J Gastroenterol Hepatol. 2018 May;30(5):546-551. doi: 10.1097/MEG.0000000000001106.

PMID:
29494353
13.

Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC).

Nakayama T, Sagara Y, Takashima T, Matsunami N, Masuda N, Miyoshi Y, Taguchi T, Aono T, Ito T, Kagimura T, Noguchi S.

Cancer Chemother Pharmacol. 2018 Apr;81(4):755-762. doi: 10.1007/s00280-018-3544-5. Epub 2018 Feb 21.

14.

NMR analysis of substrate binding to a two-domain chitinase: Comparison between soluble and insoluble chitins.

Takashima T, Ohnuma T, Fukamizo T.

Carbohydr Res. 2018 Mar 22;458-459:52-59. doi: 10.1016/j.carres.2018.02.004. Epub 2018 Feb 8.

PMID:
29459179
15.

[A Case of Bladder Metastasis from Breast Cancer].

Goto W, Kashiwagi S, Asano Y, Takada K, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1933-1935. Japanese.

PMID:
29394825
16.

[A Case of Breast Cancer Associated with Dermatitis That Was Difficult to Differentiate from Dermatomyositis].

Goto W, Kashiwagi S, Asano Y, Takada K, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1930-1932. Japanese.

PMID:
29394824
17.

[Experience with Using the EnCor ENSPIRE®System in Mammary Tissue Biopsy].

Sera T, Kashiwagi S, Takada K, Goto W, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1832-1834. Japanese.

PMID:
29394791
18.

[Prognostic Analysis of Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy Using QOL-ACD].

Fukui Y, Kashiwagi S, Takada K, Goto W, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1092-1094. Japanese.

PMID:
29394544
19.

[A Case of Ductal Carcinoma In Situ in Sclerosing Adenosis].

Fukui Y, Kashiwagi S, Takada K, Goto W, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1089-1091. Japanese.

PMID:
29394543
20.

[A Case of Adenoma of the Nipple Suspected of Breast Cancer].

Takada K, Kashiwagi S, Goto W, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1071-1073. Japanese.

PMID:
29394537

Supplemental Content

Loading ...
Support Center